Not Medicare Enrolled

Dr. Jose Ferreira, MD

Optician · Tampa, FL
Speaking/Promotional
508 S HABANA AVE, Tampa, FL 33609
8138737367
In practice since 2006 (19 years)
NPI: 1861433559 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ferreira from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ferreira? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ferreira

Dr. Jose Ferreira is an optician specialist in Tampa, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Ferreira received a total of $97,841 from 59 pharmaceutical and/or device companies across 856 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ferreira is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $97,841 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 65761 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$97,841
Total received (2018-2024)
Avg $13,977/year across 7 years
Top 3% in FL for optician
59
Companies
856
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$73,929 (75.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,391 (18.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,522 (5.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,119
2023
$2,598
2022
$2,821
2021
$3,210
2020
$6,942
2019
$57,454
2018
$15,697

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AQUESTIVE THERAPEUTICS, INC.
$21,351
EISAI INC.
$21,287
Eisai Inc.
$8,685
Greenwich Biosciences, Inc.
$8,282
Sunovion Pharmaceuticals Inc.
$8,080
UCB, Inc.
$8,043
Supernus Pharmaceuticals, Inc.
$5,867
LivaNova USA, Inc.
$5,593
H. Lundbeck A S
$1,703
Tris Pharma Inc
$1,131
JAZZ PHARMACEUTICALS INC.
$935
Jazz Pharmaceuticals Inc.
$727
Neurelis, Inc.
$599
SK Life Science, Inc.
$579
Marinus Pharmaceuticals, Inc.
$449
Shire North American Group Inc
$367
Corium, LLC
$358
Takeda Pharmaceuticals U.S.A., Inc.
$350
Lundbeck LLC
$347
CATALYST PHARMACEUTICALS, INC.
$339
Ironshore Pharmaceuticals Inc.
$287
Sumitomo Pharma America, Inc.
$265
Corium, Inc.
$174
Catalyst Pharmaceuticals, Inc.
$167
Neos Therapeutics, LP
$146
Novartis Pharmaceuticals Corporation
$144
NEUROPACE, INC.
$129
Zogenix Inc.
$114
Vertical Pharmaceuticals, LLC
$113
Biogen, Inc.
$107
IRONSHORE PHARMACEUTICALS INC.
$99
Noven Therapeutics, LLC
$98
BioMarin Pharmaceutical Inc.
$79
Travere Therapeutics, Inc.
$77
Upsher-Smith Laboratories LLC
$76
ACADIA Pharmaceuticals Inc
$63
Teva Pharmaceuticals USA, Inc.
$59
Amneal Pharmaceuticals LLC
$56
Cranial Technologies, Inc
$47
Azurity Pharmaceuticals, Inc.
$44
Mallinckrodt LLC
$42
Rhodes Pharmaceuticals L.P.
$33
Aprecia Pharmaceuticals, LLC
$33
PTC Therapeutics, Inc.
$29
Arbor Pharmaceuticals, Inc.
$28
Adlon Therapeutics L.P.
$28
BIOCODEX, INC.
$28
Boston Scientific Corporation
$24
Retrophin, Inc.
$24
Avion Pharmaceuticals
$21
NS Pharma, Inc.
$20
Sarepta Therapeutics, Inc.
$18
Lupin Inc.
$17
Mallinckrodt Enterprises LLC
$16
Avanir Pharmaceuticals, Inc.
$14
Aucta Pharmaceuticals, Inc.
$13
OWP Pharmaceuticals, Inc.
$12
PFIZER INC.
$12
Cadwell Industries, INC
$12
Top 3 companies account for 52.5% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADHANSIA XR · AFINITOR · APTIOM · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Austedo XR · Azstarys · Brineura · Briviact · COTEMPLA XR-ODT · Cholbam · DAYBUE · DIACOMIT · DIVIGEL · Doc Band · Dyanavel XR · EMFLAZA · EPIDIOLEX · EXONDYS 51 · Epidiolex · Eprontia · FYCOMPA · Fintepla · Fycompa · GILENYA · Horizant · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LYVISPAH · METHERGINE · METHYLPHENIDATE 72 · MYDAYIS · Methylphenidate Hydrochloride · Motpoly XR · NUEDEXTA · Nayzilam · ONFI · OXTELLAR XR · Onyda XR · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QUILLICHEW ER · Qelbree · Quillichew ER · Quillivant · Quillivant XR · RELEXXII · RNS Neurostimulator Kit · Relexxii · SKYCLARYS · SPINRAZA · SUNOSI · SYMPAZAN · Spritam · Subvenite · TOPIRAMATE Extended Release Capsules · TROKENDI XR · VALTOCO · VIGADRONE (VIGABATRIN) FOR ORAL SOLUTION · VIGADRONE (vigabatrin) for Oral Solution · VILTEPSO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VOXZOGO 1.2mg · VYVANSE · Varithena Administration Pack · Vimizim · Vimpat · Vyvanse · XCOPRI · XYREM · Xelstrym · Xyrem · ZONISADE · ZTALMY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for optician in FL.

Looking for an optician specialist in Tampa?
Compare opticians in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
523
Per 100K population
35.1
County median income
$75,011
Nearest hospital
HCA FLORIDA SOUTH TAMPA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ferreira is an optician specialist, with speaking/promotional industry engagement in the top 3% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Ferreira receive payments from pharmaceutical companies?
Yes. Dr. Ferreira received a total of $97,841 from 59 companies across 856 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Ferreira) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →